Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1994 1
1997 2
1999 3
2002 1
2003 2
2005 1
2007 3
2008 1
2009 1
2010 3
2011 5
2012 4
2013 3
2014 9
2015 6
2016 4
2017 7
2018 5
2019 2
2020 13
2021 13
2022 6
2023 11
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

100 results

Results by year

Filters applied: . Clear all
Page 1
Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup.
Vergote I, Gonzalez-Martin A, Lorusso D, Gourley C, Mirza MR, Kurtz JE, Okamoto A, Moore K, Kridelka F, McNeish I, Reuss A, Votan B, du Bois A, Mahner S, Ray-Coquard I, Kohn EC, Berek JS, Tan DSP, Colombo N, Zang R, Concin N, O'Donnell D, Rauh-Hain A, Herrington CS, Marth C, Poveda A, Fujiwara K, Stuart GCE, Oza AM, Bookman MA; participants of the 6th Gynecologic Cancer InterGroup (GCIG) Ovarian Cancer Consensus Conference on Clinical Research. Vergote I, et al. Among authors: kridelka f. Lancet Oncol. 2022 Aug;23(8):e374-e384. doi: 10.1016/S1470-2045(22)00139-5. Lancet Oncol. 2022. PMID: 35901833 Free PMC article. Review.
Optimal treatment in locally advanced cervical cancer.
Gennigens C, De Cuypere M, Hermesse J, Kridelka F, Jerusalem G. Gennigens C, et al. Among authors: kridelka f. Expert Rev Anticancer Ther. 2021 Jun;21(6):657-671. doi: 10.1080/14737140.2021.1879646. Epub 2021 Mar 11. Expert Rev Anticancer Ther. 2021. PMID: 33472018 Free article. Review.
PARa-aOrtic LymphAdenectomy in locally advanced cervical cancer (PAROLA trial): a GINECO, ENGOT, and GCIG study.
Martinez A, Lecuru F, Bizzarri N, Chargari C, Ducassou A, Fagotti A, Fanfani F, Scambia G, Cibula D, Díaz-Feijoo B, Gil Moreno A, Angeles MA, Muallem MZ, Kohler C, Luyckx M, Kridelka F, Rychlik A, Gerestein KG, Heinzelmann V, Ramirez PT, Frumovitz M, Ferron G, Betrian S, Filleron T, Fotopoulou C, Querleu D; PAROLA Study group. Martinez A, et al. Among authors: kridelka f. Int J Gynecol Cancer. 2023 Feb 6;33(2):293-298. doi: 10.1136/ijgc-2022-004223. Int J Gynecol Cancer. 2023. PMID: 36717163 Clinical Trial.
[Role of metformin in gynaecology and obstetrics].
Scheen AJ, Philips JC, Kridelka F. Scheen AJ, et al. Among authors: kridelka f. Rev Med Liege. 2018 Dec;73(12):597-602. Rev Med Liege. 2018. PMID: 30570229 Free article. Review. French.
Multicentric development and evaluation of 18F-FDG PET/CT and MRI radiomics models to predict para-aortic lymph node involvement in locally advanced cervical cancer.
Lucia F, Bourbonne V, Pleyers C, Dupré PF, Miranda O, Visvikis D, Pradier O, Abgral R, Mervoyer A, Classe JM, Rousseau C, Vos W, Hermesse J, Gennigens C, De Cuypere M, Kridelka F, Schick U, Hatt M, Hustinx R, Lovinfosse P. Lucia F, et al. Among authors: kridelka f. Eur J Nucl Med Mol Imaging. 2023 Jul;50(8):2514-2528. doi: 10.1007/s00259-023-06180-w. Epub 2023 Mar 9. Eur J Nucl Med Mol Imaging. 2023. PMID: 36892667 Free article.
[An update in intrauterine contraception].
Mawet M, Chabbert Buffet N, Gerard M, Nisolle M, Kridelka F, Pintiaux A. Mawet M, et al. Among authors: kridelka f. Rev Med Liege. 2022 Sep;77(9):521-526. Rev Med Liege. 2022. PMID: 36082599 Free article. French.
The pre-metastatic niche in lymph nodes: formation and characteristics.
Gillot L, Baudin L, Rouaud L, Kridelka F, Noël A. Gillot L, et al. Among authors: kridelka f. Cell Mol Life Sci. 2021 Aug;78(16):5987-6002. doi: 10.1007/s00018-021-03873-z. Epub 2021 Jul 9. Cell Mol Life Sci. 2021. PMID: 34241649 Free PMC article. Review.
Statement of the AGO Kommission Ovar, AGO Study Group, NOGGO, AGO Austria, Swiss AGO, BGOG, CEEGOG, GEICO, and SFOG regarding the use of hyperthermic intraperitoneal chemotherapy (HIPEC) in epithelial ovarian cancer.
Harter P, Bogner G, Chiva L, Cibula D, Concin N, Fotopoulou C, Gonzalez-Martin A, Guyon F, Heinzelmann-Schwarz V, Kridelka F, Mahner S, Marmé F, Marth C, Morice P, Novák Z, Papadia A, Ray-Coquard I, Redecha M, Redondo A, Schwameis R, Sehouli J, Undurraga M, Van Gorp T, Vergote I. Harter P, et al. Among authors: kridelka f. Bull Cancer. 2024 Mar;111(3):277-284. doi: 10.1016/j.bulcan.2023.02.011. Epub 2023 Mar 24. Bull Cancer. 2024. PMID: 36967330 Review.
Fifth Ovarian Cancer Consensus Conference: individualized therapy and patient factors.
McGee J, Bookman M, Harter P, Marth C, McNeish I, Moore KN, Poveda A, Hilpert F, Hasegawa K, Bacon M, Gatsonis C, Brand A, Kridelka F, Berek J, Ottevanger N, Levy T, Silverberg S, Kim BG, Hirte H, Okamoto A, Stuart G, Ochiai K; participants of the 5th Ovarian Cancer Consensus Conference. McGee J, et al. Among authors: kridelka f. Ann Oncol. 2017 Apr 1;28(4):702-710. doi: 10.1093/annonc/mdx010. Ann Oncol. 2017. PMID: 28119296 Free article.
100 results